CH Pharmaconsulting SRL
CH Pharmaconsulting reported total assets of 46,189 € at the end of the 2025 financial year (annual accounts filed with the NBB on 02 Apr 2026).
The score of CH Pharmaconsulting shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2025
Change 2022 → 2025: Equity -54 % Total assets -51 %
Accounts of the company itself (not consolidated).
The full file covers 4 financial years; a free account shows 2. →Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
CH Pharmaconsulting's annual accounts
Filed annual accounts
- Year ended 31 Dec 2025filed on 02 Apr 2026
- Year ended 31 Dec 2024filed on 16 Jun 2025
- Year ended 31 Dec 2023filed on 11 Jun 2024
- Year ended 31 Dec 2022filed on 22 Jun 2023
CH Pharmaconsulting's financial analysis
- Solvency88.5%sector median: 52.2%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of CH Pharmaconsulting
CH Pharmaconsulting's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 0780.468.928
- VAT number
- BE0780468928
- Peppol
- Registered · 0208:0780468928 · as of 10 Nov 2026
- Legal form
- SRL
- Incorporated
- 14 Jan 2022
- Registered office
- 1150 Woluwe-Saint-Pierre
- Latest accounts
- 2025 · filed on 02 Apr 2026
- Activity
- Other liberal professions and professional, scientific and technical activities n.e.c. (NACE 74999)
CH Pharmaconsulting (SRL) has been based in Woluwe-Saint-Pierre since 2022, active in: other liberal professions and professional, scientific and technical activities n.e.c.. For 2025, it reports a net loss of 27,517 € and equity of 40,857 €; its revenue is not published. Its solvency stands at 88.5%, above the median of its sector (52.2%).
Guide: Reading Belgian SME accounts: the five figures that count →
Companies similar to CH Pharmaconsulting
Companies in the same business, of comparable size and area, outside its group.
- Beyond Bar Code All other professional, scientific and technical activities n.e.c. Brussels · balance sheet 46,095 €
- Kick Off Management All other professional, scientific and technical activities n.e.c. Ixelles · balance sheet 44,750 €
- Media 21 All other professional, scientific and technical activities n.e.c. Uccle · balance sheet 44,577 €
- IMMoen All other professional, scientific and technical activities n.e.c. Schaerbeek · balance sheet 50,693 €
- VMG Ventures All other professional, scientific and technical activities n.e.c. Brussels · balance sheet 41,169 €
- CleverSystems All other professional, scientific and technical activities n.e.c. Wavre · balance sheet 40,950 €
- ASP Consult All other professional, scientific and technical activities n.e.c. Evere · balance sheet 52,752 €
- ET&C All other professional, scientific and technical activities n.e.c. Wavre · balance sheet 38,199 €
Frequently asked questions about CH Pharmaconsulting
What is the revenue of CH Pharmaconsulting?
CH Pharmaconsulting files its accounts in a format where revenue is optional: it is not published for 2025.
What is the VAT number of CH Pharmaconsulting?
In Belgium, the VAT number is the company number prefixed with BE: BE0780468928 for CH Pharmaconsulting, if the company is VAT-registered. Its company number (CBE) is 0780.468.928.
Where is the registered office of CH Pharmaconsulting?
According to the CBE register, the registered office of CH Pharmaconsulting is in 1150 Woluwe-Saint-Pierre.
What is the equity of CH Pharmaconsulting?
At the close of the 2025 financial year, the equity of CH Pharmaconsulting amounts to 40,857 €, a solvency of 88.5% of total assets.
Who manages CH Pharmaconsulting?
The register lists 1 active mandates at CH Pharmaconsulting. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
The full file of CH Pharmaconsulting
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →